Skip to main navigation Skip to search Skip to main content

Open-label, multicenter safety study of vemurafenib in patients with BRAF(V600) mutation-positive metastatic melanoma

  • James M. G. Larkin
  • , Michele Del Vecchio
  • , Paolo Antonio Ascierto
  • , Jacob Schachter
  • , Claus Garbe
  • , Bart Neyns
  • , Mario Mandala
  • , Paul Lorigan
  • , Wilson H. Miller
  • , Alexander David Guminski
  • , Carola Berking
  • , Piotr Rutkowski
  • , Paola Queirolo
  • , Axel Hauschild
  • , Ana Maria Arance
  • , Michael Paul Brown
  • , Lada Mitchell
  • , Maria Luisa Veronese
  • , Christian U. Blank

    Research output: Contribution to journal › Article › peer-review

    Original languageUndefined
    Article number9046
    JournalJournal of Clinical Oncology
    Volume15
    Issue numberS
    Publication statusPublished - 2013

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Cite this